Drug Trial Radar · NCT01518374
Clinical Evaluation of Florbetapir F 18 (18F-AV-45)
Last checked: Nov 19, 2026Latest source record: Jul 18, 2018 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,768
Actual
Start
Dec 2009
Primary completion
May 3, 2017
Study completion May 3, 2017
Sponsor
- Lead sponsor
- Avid RadiopharmaceuticalsIndustry
- Sponsor type
- Industry
- First posted
- Jan 26, 2012
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Diagnostic
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This protocol is designed to standardize imaging studies using florbetapir F 18 PET to provide information on amyloid burden in subjects participating in other studies (companion protocol) such as longitudinal studies of aging and studies of biomarkers for neurodegenerative diseases.
Conditions
- Alzheimer Disease
- Mild Cognitive Impairment
- Neurodegenerative Diseases
Interventions
Florbetapir F 18Drug
370 MBq (10 mCi)
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants Experiencing Treatment-emergent Adverse Events Considered Related to Florbetapir AdministrationTime frame: 48 hours
Locations
26 sites in 1 country. Site status is shown where the registry gives one.
Banner Health
Phoenix, Arizona
Banner Sun Health Research Institute
Sun City, Arizona
UC Davis
Davis, California
UC Irvine
Irvine, California
University of Southern California
Los Angeles, California
UC Irvine
Orange, California
UC San Francisco
San Francisco, California
UC San Francisco Memory Center
San Francisco, California
Mayo Clinic Jacksonville
Jacksonville, Florida
Mt. Sinai Medical Center
Miami Beach, Florida
Northwestern University
Chicago, Illinois
University of Kansas
Kansas City, Kansas
Johns Hopkins University
Baltimore, Maryland
Massachusetts General Hospital
Boston, Massachusetts
University of Mississippi Medical Center
Jackson, Mississippi
Washington University School of Medicine
St Louis, Missouri
Duke University
Durham, North Carolina
Wake Forest University
Winston-Salem, North Carolina
Jefferson
Philadelphia, Pennsylvania
University of Pennsylvania
Philadelphia, Pennsylvania
Butler Hospital
Providence, Rhode Island
University of Tennessee
Knoxville, Tennessee
Vanderbilt
Nashville, Tennessee
UTSW
Dallas, Texas
UTSW
Dallas, Texas
UTSW
Dallas, Texas
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.